Sai Parenteral’s IPO is to open on March 24, 2026. It is a Mainboard IPO that will raise â‚ą[.] crores. The Sai Parenteral’s IPO price band is fixed at â‚ą[.] with a market lot of [.] Shares.
Sai Parenteral’s IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 17 March | â‚ą- | – | -% |
Sai Parenteral’s IPO Details
| IPO Open Date | March 24, 2026 |
| IPO Close Date | March 27, 2026 |
| Face Value | â‚ą5 Per Equity Share |
| IPO Price Band | â‚ą[.] to â‚ą[.] Per Share |
| Issue Size | Approx â‚ą[.] Crores |
| Fresh Issue | Approx â‚ą285 Crores |
| Offer for Sale: | Approx 35,00,000 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Sai Parenteral’s IPO Dates
| IPO Open Date: | March 24, 2026 |
| IPO Close Date: | March 27, 2026 |
| Basis of Allotment: | March 30, 2026 |
| Refunds: | April 1, 2026 |
| Credit to Demat Account: | April 1, 2026 |
| IPO Listing Date: | April 2, 2026 |
| IPO Bidding Cut-off Time: | March 27, 2026 |
Business Overview
Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.
Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.
Sai Parenteral’s IPO GMP aka Grey Market Premium FAQs:
What is Sai Parenteral’s IPO GMP Today?
What is Sai Parenteral’s IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Sai Parenteral’s IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
